Could we be on a hat trick tomorrow. Current targets for where we are currently in progress of C-pulse is around $11-12 on Nasdaq which is double here on ASX.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%